Chemical transformation of human glial cells into neurons

October 16, 2015 by Barbara Kennedy, Pennsylvania State University
Chemical transformation of human glial cells into neurons
Astroglial cells after treatment with small-molecule cocktails in the lab of Gong Chen at Penn State University, showing transformation into neurons with long axons and dendrites. Credit: Gong Chen lab, Penn State University

For the first time, researchers have used a cocktail of small molecules to transform human brain cells, called astroglial cells, into functioning neurons for brain repair. The new technology opens the door to the future development of drugs that patients could take as pills to regenerate neurons and to restore brain functions lost after traumatic injuries, stroke, or diseases such as Alzheimer's. Previous research, such as conventional stem cell therapy, requires brain surgery and therefore is much more invasive and prone to immune-system rejection and other problems. The research, led by Gong Chen, Professor of Biology and the Verne M. Willaman Chair in Life Sciences at Penn State University, will be published online in the journal Cell Stem Cell on Oct. 15th, 2015.

"We have discovered a cocktail of small molecules that can reprogram human astroglial cells into neuron-like cells after eight-to-ten days of chemical treatment," Chen said. The neurons the researchers reprogrammed survived for more than five months in cell culture, where they formed functional synaptic networks. The scientists also injected the reprogrammed human neurons into the brains of living mice, where they integrated into the neural circuits and survived there for at least one month.

"The small molecules are not only easy to synthesize and package into drug pills, but also much more convenient for use by patients than other methods now being developed," Chen said. Before the promise of the new technology results in pills at a pharmacy, the new research effort must first succeed through much development and testing in the laboratory and then through a series of clinical trials.

The brain has nerve cells called neurons and another kind called glial cells, which include astroglial cells—both are important components of the brain's nervous system. Healthy astroglial cells surround neurons and provide them with support, protection, oxygen, and nutrients. But when brain tissues are damaged by strokes or trauma, the astroglial cells react by multiplying—sometimes so much that they clog up the nervous system by forming a scar. These astroglial scars can cause health problems by preventing nerve regeneration and by blocking nerve-to-nerve communications between different regions of the brain.

Astroglial cells after treatment with small-molecule cocktails in the lab of Gong Chen at Penn State University, showing transformation into neurons with long axons and dendrites. Credit: Gong Chen lab, Penn State University

The astroglial scars have been a difficult research challenge for many decades. Chen's group previously invented a method to convert astroglial cells into neurons using viral particles. But Chen also wanted to investigate whether small chemical compounds, which more likely could be packaged into swallowable pills, could convert astroglial cells into neurons.

Five students on Chen's research team, led by graduate student Lei Zhang, tested hundreds of different conditions and eventually identified a cocktail of small molecules that can convert human astroglial cells into functional neurons in a cell-culture dish in the laboratory. The students found that adding in a certain sequence transformed the cultured human astroglial from a flat, polygon shape into a neuron-like shape with long "arms" called axons and dendrites. "These chemically generated neurons are comparable to normal brain neurons in terms of firing electric activity and release of neurotransmitters," Chen said. "Importantly, the human astroglial-converted neurons survived longer than five months in cell culture and longer than one month in the living mouse brain after transplantation."

While Chen acknowledges that many technical issues are yet to be solved, he hopes that this may have broad applications in the future treatment of stroke, Alzheimer's disease, Parkinson's disease, and other neurological disorders. "Our dream is that, one day, patients with brain disorders can take drug pills at home to regenerate inside their brains without any brain surgery and without any cell transplantation," Chen said. "Our invention of the small-molecule cocktail helps us to make a huge step closer to that dream."

Explore further: Brain repair after injury and Alzheimer's disease

More information: Ziyuan Guo et al. In Vivo Direct Reprogramming of Reactive Glial Cells into Functional Neurons after Brain Injury and in an Alzheimer's Disease Model, Cell Stem Cell (2014). DOI: 10.1016/j.stem.2013.12.001

Related Stories

Brain repair after injury and Alzheimer's disease

December 19, 2013
Researchers at Penn State University have developed an innovative technology to regenerate functional neurons after brain injury, and also in model systems used for research on Alzheimer's disease. The scientists have used ...

Research gives new hope for restoring cells in damaged brains and spinal cords

January 20, 2015
What motivates Penn State scientists and their students to devote countless hours trying to solve tough research mysteries? For Gong Chen, a biology professor at Penn State, the answer is rooted in a desire to help relieve ...

Scientists identify how normally protective immune responses kill neurons

October 6, 2015
National Institutes of Health (NIH) scientists studying inflammation of the brain have discovered why certain immune responses, which typically help cells recognize and fight viral and bacterial infections, can sometimes ...

Alzheimer's, schizophrenia, and autism now can be studied with mature brain cells reprogrammed from skin cells

June 6, 2013
Difficult-to-study diseases such as Alzheimer's, schizophrenia, and autism now can be probed more safely and effectively thanks to an innovative new method for obtaining mature brain cells called neurons from reprogrammed ...

'Support' cells in brain play important role in Down syndrome

July 18, 2014
Researchers from UC Davis School of Medicine and Shriners Hospitals for Children – Northern California have identified a group of cells in the brain that they say plays an important role in the abnormal neuron development ...

How marijuana impairs memory

March 1, 2012
A major downside of the medical use of marijuana is the drug's ill effects on working memory, the ability to transiently hold and process information for reasoning, comprehension and learning. Researchers reporting in the ...

Recommended for you

New cell therapy aids heart recovery—without implanting cells

April 23, 2018
Heart disease is a major global health problem—myocardial infarction annually affects more than one million people in the U.S. alone, and there is still no effective treatment. The adult human heart cannot regenerate itself ...

Researchers identify blood biomarkers that may help diagnose, confirm concussions

April 20, 2018
Researchers from the University of California, Irvine, Georgetown University and the University of Rochester have found that specific small molecules in blood plasma may be useful in determining whether someone has sustained ...

DOR protein deficiency favors the development of obesity

April 20, 2018
Obesity is a world health problem. Excessive accumulation of fat tissue (adipose tissue) increases the risk of cardiovascular disease, hypertension, diabetes and some types of cancer. However, some obese individuals are less ...

Stem-cell technology aids 3-D printed cartilage repair

April 20, 2018
Novel stem-cell technology developed at Swinburne will be used to grow the massive number of stem cells required for a new hand-held 3-D printer that will enable surgeons to create patient-specific bone and cartilage.

Enduring cold temperatures alters fat cell epigenetics

April 19, 2018
A new study in fat cells has revealed a molecular mechanism that controls how lifestyle choices and the external environment affect gene expression. This mechanism includes potential targets for next-generation drug discovery ...

Defect in debilitating neurodegenerative disease reversed in mouse nerves

April 19, 2018
Scientists have developed a new drug compound that shows promise as a future treatment for Charcot-Marie-Tooth disease, an inherited, often painful neurodegenerative condition that affects nerves in the hands, arms, feet ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.